13,998 results match your criteria transurethral resection


Isotonic saline causes greater volume overload than electrolyte-free irrigating fluids.

Authors:
Robert G Hahn

J Basic Clin Physiol Pharmacol 2021 Sep 27. Epub 2021 Sep 27.

Research Unit, Södertälje Hospital, Södertälje, Sweden.

Objectives: Systemic absorption of the irrigating fluid used to flush the operating site is a potentially serious complication in several types of endoscopic operations. To increase safety, many surgeons have changed from a monopolar to a bipolar resection technique because 0.9% saline can then be used instead of electrolyte-free fluid for irrigation. Read More

View Article and Full-Text PDF
September 2021

Invited Commentary: Prostatic Artery Embolization Versus Transurethral Resection of the Prostate: A Post Hoc Cost Analysis of a Randomized Controlled Clinical Trial, By Capdevila et al.

Authors:
Charles E Ray

Cardiovasc Intervent Radiol 2021 Sep 24. Epub 2021 Sep 24.

Department of Radiology, University of Illinois College of Medicine, 1740 W. Taylor St, Chicago, IL, 60614, USA.

View Article and Full-Text PDF
September 2021

Utility of D2-40, Cytokeratin 5/6, and High-Molecular-weight Cytokeratin (Clone 34βE12) in Distinguishing Intraductal Spread of Urothelial Carcinoma From Prostatic Stromal Invasion.

Am J Surg Pathol 2021 Sep 23. Epub 2021 Sep 23.

Departments of Pathology and Laboratory Medicine Urology Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL.

Intraductal spread of urothelial carcinoma (UC) is not an uncommon finding in bladder cancer that requires appropriate clinical management. The presence of prostatic stromal invasion in non-muscle-invasive bladder cancer upstages the disease, necessitating cisplatin-based neoadjuvant chemotherapy and subsequent cystroprostatectomy. However, the identification of prostatic stromal invasion can be challenging, especially in biopsy and transurethral resection specimens. Read More

View Article and Full-Text PDF
September 2021

Rapidly recurrent prostatic obstruction due to granulomatosis with polyangiitis.

Urol Case Rep 2021 Nov 7;39:101771. Epub 2021 Jul 7.

Anatpath, 120 Gardenvale Road, Gardenvale, VIC, 3185, Australia.

Granulomatosis with polyangiitis (GPA) is a rare cause of prostatitis. Our case illustrates a case of granulomatous prostatitis secondary to unrecognised GPA requiring multiple surgical interventions. The patient presented with lower urinary tract symptoms. Read More

View Article and Full-Text PDF
November 2021

Prognostic value of prostate volume in non-muscle invasive bladder cancer.

Sci Rep 2021 Sep 22;11(1):18784. Epub 2021 Sep 22.

Department of Urology and Urological Science Institute, Yonsei University College of Medicine, Seoul, South Korea.

There is evidence that a history of benign prostatic hyperplasia increases the incidence of bladder cancer, and treatment with 5-alpha reductase inhibitor or androgen deprivation therapy reduces recurrence of non-muscle invasive bladder cancer. We aimed to evaluate whether prostate volume affects its prognosis. We reviewed medical records of men who underwent transurethral resection of bladder tumor due to non-muscle invasive bladder cancer from January 2012 to December 2017. Read More

View Article and Full-Text PDF
September 2021

Early Efficacy and Safety Outcomes of Artificial Urinary Sphincter for Stress Urinary Incontinence Following Radical Prostatectomy or Benign Prostatic Obstruction Surgery: Results of a Large Multicentric Study.

Eur Urol Focus 2021 Sep 18. Epub 2021 Sep 18.

Department of Urology, Charles Nicolle University Hospital, Rouen, France.

Background: Artificial urinary sphincter (AUS) is the gold standard for the management of moderate to severe stress urinary incontinence (SUI) in the male population. While outcomes of this device in postprostatectomy incontinence (PPI) are widely described, those obtained for incontinence after benign prostatic obstruction (BPO) surgery remains poorly explored.

Objective: To compare continence outcomes after AUS implantation in a PPI population with those obtained in men incontinent after BPO surgery. Read More

View Article and Full-Text PDF
September 2021

Factors Associated with Re-resection in T1 Bladder Cancer: Identifying Patients Who do Not Receive Guideline-Concordant Care at the Population Level.

J Urol 2021 Sep 22:101097JU0000000000002229. Epub 2021 Sep 22.

Division of Urology, Department of Surgery, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.

Purpose: Prior research has shown that concordance with the guideline-endorsed recommendation to re-resect patients diagnosed with primary T1 bladder cancer (BC) is suboptimal. Therefore, the aim of this population-based study was to identify factors associated with re-resection in T1 BC.

Materials And Methods: We linked province-wide BC pathology reports (January 2001 to December 2015) with health administrative data sources to derive an incident cohort of patients diagnosed with T1 BC in the province of Ontario, Canada. Read More

View Article and Full-Text PDF
September 2021

Mirabegron improves the irritative symptoms caused by BCG immunotherapy after transurethral resection of bladder tumors.

Cancer Med 2021 Sep 21. Epub 2021 Sep 21.

Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China.

Background: This study aims to explore the efficacy and safety of mirabegron in treating irritative symptoms induced by intravesical immunotherapy with Bacillus Calmette-Guerin (BCG) after transurethral resection of bladder tumors (TURBT).

Methods: A total of 160 patients subjected to TURBT was randomly divided into the mirabegron group and placebo group with 80 patients in each group. Then, the patients were administered 25 mg mirabegron or placebo daily, starting the first day after BCG infusion. Read More

View Article and Full-Text PDF
September 2021

Immune escape mechanisms and immunotherapy of urothelial bladder cancer.

J Clin Transl Res 2021 Aug 30;7(4):485-500. Epub 2021 Jul 30.

Department of Biomedical Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.

Background And Aim: Urothelial bladder cancer (UBC) is a common malignant tumor of the urogenital system with a high rate of recurrence. Due to the sophisticated and largely unexplored mechanisms of tumorigenesis of UBC, the classical therapeutic approaches including transurethral resection and radical cystectomy combined with chemotherapy have remained unchanged for decades. However, with increasingly in-depth understanding of the microenvironment and the composition of tumor-infiltrating lymphocytes of UBC, novel immunotherapeutic strategies have been developed. Read More

View Article and Full-Text PDF

Salvage of a Near-Total Penile Amputation following Urinary Fistulization and Carbapenemase-Producing Infection with a Composite ALT Flap and Vascularized Fascia Lata.

Surg J (N Y) 2021 Jul 14;7(3):e237-e240. Epub 2021 Sep 14.

Department of Urology, Centro Hospitalar Universitário São João, Faculty of Medicine, University of Porto, Porto, Portugal.

Reconstruction of complex penile defects is always challenging, as some defects are not possible to reconstruct with skin or mucosa grafts, and even local flaps may be precluded in complex wounds. We present a case of a 63-year-old otherwise healthy man, who underwent transurethral resection of the prostate for benign prostatic hyperplasia. After the procedure, he developed panurethral necrosis with consequent stricture. Read More

View Article and Full-Text PDF

Surgical management of benign prostate hyperplasia in Nigeria: open prostatectomy versus transurethral resection of the prostate.

Pan Afr Med J 2021 2;39:165. Epub 2021 Jul 2.

Department of Surgery, Jos University Teaching Hospital (JUTH), Jos, Nigeria.

Introduction: transvesical (open) prostatectomy (OP), an invasive surgical procedure, is a common form of treatment offered to patients with benign prostatic enlargement in emerging economies. Recently, there has been an increase in the use of electrosurgical means in treating benign prostate hyperplasia in our environment, especially transurethral resection of the prostate (TURP). This study compares the perioperative, short-term outcomes and complications of open prostatectomy and TURP. Read More

View Article and Full-Text PDF

Combination of transurethral resection of the prostate and flexible and rigid ureteroscopy for benign prostatic hyperplasia and ureteral calculus.

Transl Androl Urol 2021 Aug;10(8):3395-3401

Department of Urology Surgery, Hengshui People's Hospital, Hengshui, China.

Background: Combination of transurethral resection of the prostate (TURP) and flexible and rigid ureteroscopy (URS/RIRS) is a successful approach for patients with benign prostatic hyperplasia (BPH) and ureteral calculus (UC), and the sequence is URS/RIRS followed by TURP. This research aims to compare TURP followed by URS/RIRS with URS/RIRS followed by TURP in terms of clinical efficiency and safety.

Methods: From June 2009 to June 2021, 173 patients with BPH and upper urinary tract stones were recruited through the Harrison International Peace Hospital and were divided into intervention (TURP followed by URS/RIRS) and control groups (URS/RIRS followed by TURP). Read More

View Article and Full-Text PDF

Pulmonary and hepatic metastases of low-grade urothelial cell carcinoma; A case report.

Urol Case Rep 2021 Nov 4;39:101836. Epub 2021 Sep 4.

Franciscan Health Olympia Fields, 20201 South, Crawford Ave, Olympia Fields, IL, 60461, USA.

Bladder cancer is a commonly encountered malignancy of the genitourinary tract. Bladder cancer is categorized as high or low grade depending on histological analysis. Low grade urothelial cell carcinoma has an indolent clinical course as compared to high grade, with low rates of progression of disease. Read More

View Article and Full-Text PDF
November 2021

Associations Between Kidney Dysfunction and Risk Factors in Patients with Transurethral Resection of the Prostate.

Res Rep Urol 2021 7;13:665-672. Epub 2021 Sep 7.

Medical Faculty of Riau University, Pekanbaru, Riau, Indonesia.

Purpose: Benign prostate hyperplasia (BPH) with urinary retention can result in kidney dysfunction. Several risk factors might influence deterioration in kidney function. The aims of this study were to assess the association between kidney dysfunction and risk factors in patients with transurethral resection of the prostate (TURP). Read More

View Article and Full-Text PDF
September 2021

Usefulness of advanced monoenergetic reconstruction technique in dual-energy computed tomography for detecting bladder cancer.

Jpn J Radiol 2021 Sep 13. Epub 2021 Sep 13.

Department of Radiology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Japan.

Purpose: Detecting bladder cancer (BC) in routine CT images is important but is sometimes difficult when cancer is small. We evaluated the ability of 40-keV advanced monoenergetic images to depict BC.

Materials And Methods: Fifty-two patients with a median age of 74 years (range 45-92) who were diagnosed as BC with transurethral resection or cystectomy, were included. Read More

View Article and Full-Text PDF
September 2021

Discrepancy between German S3 Guideline Recommendations and Daily Urologic Practice in the Management of Nonmuscle Invasive Bladder Cancer: Results of a Binational Survey.

Urol Int 2021 Aug 31:1-11. Epub 2021 Aug 31.

Department of Urology, Clinic LINKS VOM RHEIN, Cologne, Germany.

Introduction: Guideline recommendations are meant to help minimize morbidity and to improve the care of nonmuscle invasive bladder cancer (NMIBC) patients but studies have suggested an underuse of guideline-recommended care. The aim of this study was to evaluate the level of adherence of German and Austrian urologists to German guideline recommendations.

Methods: A survey of 27 items evaluating diagnostic and therapeutic recommendations (15 cases of strong consensus and 6 cases of consensus) for NMIBC was administered among 14 urologic training courses. Read More

View Article and Full-Text PDF

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ).

Eur Urol 2021 Sep 9. Epub 2021 Sep 9.

European Association of Urology, Arnhem, The Netherlands.

Context: The European Association of Urology (EAU) has released an updated version of the guidelines on non-muscle-invasive bladder cancer (NMIBC).

Objective: To present the 2021 EAU guidelines on NMIBC.

Evidence Acquisition: A broad and comprehensive scoping exercise covering all areas of the NMIBC guidelines since the 2020 version was performed. Read More

View Article and Full-Text PDF
September 2021

Clinicopathological features and oncological outcomes of urothelial carcinoma involving the ureterovesical junction.

Jpn J Clin Oncol 2021 Sep 11. Epub 2021 Sep 11.

Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Background: The ureterovesical junction is the boundary between the urinary bladder and upper urinary tract. Because treatment strategies for bladder cancer and upper tract urothelial carcinoma are entirely different, urothelial carcinoma involving the ureterovesical junction requires special attention. Nevertheless, studies focusing on the disease are lacking. Read More

View Article and Full-Text PDF
September 2021

Glomangiomyoma of Uncertain Malignant Potential in the Urinary Bladder: A Case Report.

JNMA J Nepal Med Assoc 2021 Jul 30;59(239):719-722. Epub 2021 Jul 30.

Department of General Surgery, B&B Hospital Private Limited, Gwarko, Lalitpur, Nepal.

Glomus tumour typically occurs in subcutaneous tissue but rarely in the visceral organs. Most glomus tumours are benign but few atypical glomus tumours have been reported. Herein, we report a case of a 44-year-old male who presented with hematuria. Read More

View Article and Full-Text PDF

Median Duration of Hospital Stay after Early Removal of Foley's Catheter among Patients Undergoing Transurethral Resection of Prostate: A Descriptive Cross-sectional Study.

JNMA J Nepal Med Assoc 2021 Jul 30;59(239):688-691. Epub 2021 Jul 30.

Department of Surgery, National Medical College, Birgunj, Nepal.

Introduction: Transurethral resection of the prostate requires a catheter in situ post-surgery. Early removal of catheter can reduce the length of hospital stay reducing the healthcare cost. It can also reduce the risk of infection due to prolonged catheterization. Read More

View Article and Full-Text PDF

Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer.

Sci Rep 2021 Sep 9;11(1):17981. Epub 2021 Sep 9.

Department of Urology, University of Regensburg, Caritas St. Josef Medical Center, Landshuter Str. 65, 93053, Regensburg, Germany.

Tumor budding is defined as a single cell or a cluster of up to 5 tumor cells at the invasion front. Due to the difficulty of identifying patients at high risk for pT1 non-muscle-invasive bladder cancer (NMIBC) and the difficulties in T1 substaging, tumor budding was evaluated as a potential alternative and prognostic parameter in these patients. Tumor budding as well as growth pattern, invasion pattern and lamina propria infiltration were retrospectively evaluated in transurethral resection of the bladder (TURB) specimens from 92 patients with stage pT1 NMIBC. Read More

View Article and Full-Text PDF
September 2021

Multi-Institutional Study of Dorsal Onlay Urethroplasty of the Membranous Urethra after Endoscopic Prostate Procedures: Operative Results, Continence, Erectile Function and Patient Reported Outcomes.

J Clin Med 2021 Sep 2;10(17). Epub 2021 Sep 2.

Department of Urology, SUNY Upstate Medical University, Syracuse, NY 13210, USA.

(1) Background: To critically evaluate dorsal onlay buccal mucosal graft urethroplasty (DOBMGU) for posterior urethral stenosis repair following transurethral resection and other endoscopic prostate procedures. (2) Methods: A retrospective multi-institutional review of patients with membranous or bulbomembranous urethral stenosis for whom treatment with DOBMGU was conducted after receipt of prostate endoscopic procedures. Baseline data, peri-operative care, post-operative care and patient-reported outcomes were analyzed. Read More

View Article and Full-Text PDF
September 2021

Pyuria as a Predictive Marker of Bacillus Calmette-Guérin Unresponsiveness in Non-Muscle Invasive Bladder Cancer.

J Clin Med 2021 Aug 24;10(17). Epub 2021 Aug 24.

Department of Urology, Seoul National University Hospital, Seoul 03080, Korea.

This study aims to investigate the clinical role of preoperative pyuria for predicting bacillus Calmette-Guérin (BCG) unresponsiveness in non-muscle invasive bladder cancer (NMIBC). We performed a logistic regression analysis on 453 patients with NMIBC who were treated with BCG immunotherapy after a transurethral resection of bladder tumours, to evaluate predictive factors of BCG unresponsiveness. We also analysed univariate and multivariable survival data to estimate the prognostic impact of pyuria. Read More

View Article and Full-Text PDF

Transurethral Resection of Bladder Tumor: Electrosurgical and Laser.

J Endourol 2021 Sep;35(S2):S46-S51

Department of Urology, Campus Biomedico University of Rome, Rome, Italy.

Transurethral resection of bladder tumor (TURBT) is still the gold standard for the diagnosis, treatment, and staging of nonmuscle invasive bladder cancer. En bloc resection of bladder tumor (EBRT) has been recently introduced to overcome the limitations of conventional TURBT. EBRT potential advantages are (1) complete resection, (2) a more precise and controlled resection (potentially fewer complications), (3) better sample orientation for histopathology analysis, (4) presence of detrusor in the specimen, and (5) less tumor seeding on normal urothelium by tumor fragments. Read More

View Article and Full-Text PDF
September 2021

Prediction of neo-adjuvant chemotherapy response in bladder cancer: the impact of clinical parameters and routine biomarkers.

Scand J Urol 2021 Sep 9:1-7. Epub 2021 Sep 9.

Department of Pathology (HUSLAB), Helsinki University Hospital and University of Helsinki, Helsinki, Finland and FIMM.

Purpose: To investigate the role of clinical parameters and immunohistochemical (IHC) biomarkers in their feasibility to predict the effect of neo-adjuvant chemotherapy (NAC) in patients with muscle-invasive urothelial bladder cancer (MIBC).

Materials And Methods: The first 76 consecutive patients with MIBC treated with NAC and radical cystectomy in two University hospitals in Finland between 2008 and 2013 were chosen for this study. After excluding patients with non-urothelial cancer, less than two cycles of chemotherapy, no tissue material for IHC analysis or non-muscle-invasive bladder cancer in re-review, 59 patients were included in the final analysis. Read More

View Article and Full-Text PDF
September 2021

Muscle invasive urinary bladder urothelial carcinoma presenting with secondary nephrotic symptoms.

IJU Case Rep 2021 Sep 28;4(5):314-317. Epub 2021 Jun 28.

Department of Pathology and Laboratory Medicine National Hospital Organization Shinshu Ueda Medical Center Ueda Nagano Japan.

Introduction: Nephrotic syndrome secondary to malignant disease accounts for approximately 10% of cases of nephrotic syndrome in adults. However, urothelial carcinoma of the bladder is a rare cancer, with only four cases reported to date.

Case Presentation: A 76-year-old man presented with chief complaints of edema and anorexia. Read More

View Article and Full-Text PDF
September 2021

Multiple Primary Tumors Originating From the Prostate and Colorectum A Clinical-Pathological and Therapeutic Challenge.

Am J Mens Health 2021 Sep-Oct;15(5):15579883211044881

Department of Orthopedic Surgery-Traumatology-Urology-Medical Imaging-Urology Department, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.

Considering that the incidence of colorectal (CRC) and prostatic cancer (PC) increases with age, metachronous and synchronous tumors can often affect the same patient. Despite the importance of this subject for the diagnosis and management of oncologic patients, in medical literature the data are scarce. The aim of the study was to evaluate the incidence and the characteristics of double/multiple primary malignant tumors (D/MPMTs) with colorectal and prostatic origin, in patients admitted to a reference hospital in West Romania. Read More

View Article and Full-Text PDF
September 2021

Primary melanoma of the bladder: a case report and review of the literature.

Eur Rev Med Pharmacol Sci 2021 Aug;25(16):5122-5128

Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, Pavia, Italy.

Objective: Primary bladder melanomas are rare and aggressive neoplasms. We herein described a new case and performed a review of the literature.

Patients And Methods: We present the case of a 81-year-old woman with a primary mucosal melanoma of the bladder after a history of acral melanoma (KRAS mutated) and lentigo maligna of the forehead. Read More

View Article and Full-Text PDF

Enhanced Visualization Methods for First Transurethral Resection of Bladder Tumour in Suspected Non-muscle-invasive Bladder Cancer: A Health Technology Assessment.

Authors:

Ont Health Technol Assess Ser 2021 12;21(12):1-123. Epub 2021 Aug 12.

Background: Bladder cancer begins in the innermost lining of the bladder wall and, on histological examination, is classified as one of two types: non-muscle-invasive bladder cancer (NMIBC) or muscle-invasive bladder cancer. Transurethral resection of bladder tumour (TURBT) is the standard treatment for people with NMIBC, but the high rate of cancer recurrence after first TURBT is a challenge that physicians and patients face. Tumours seen during follow-up may have been missed or incompletely resected during first TURBT. Read More

View Article and Full-Text PDF

Patients with renal transplant and moderate-to-severe LUTS benefit from urodynamic evaluation and early transurethral resection of the prostate.

World J Urol 2021 Sep 4. Epub 2021 Sep 4.

Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Padova, Italy.

Purpose: To assess long-term renal function and micturition pattern of males submitted to transurethral resection of the prostate (TURP) for moderate-to-severe lower urinary tract symptoms (LUTS) after renal transplantation (RT). To investigate the role of clinical and urodynamic (UD) parameters for bladder outlet obstruction (BOO) diagnosis in these patients.

Methods: Retrospective data analysis of ≥ 50 years old patients who underwent RT between 01/2005 and 12/2016. Read More

View Article and Full-Text PDF
September 2021